---
title: Serum metabolomic profiling for patients with adenocarcinoma of the esophagogastric
  junction
date: '2022-04-19'
linkTitle: http://link.springer.com/10.1007/s11306-022-01883-x
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">The
  incidence of adenocarcinoma in the esophagogastric junction (AEG) has increased
  in the recent years. AEG is reported to have a worse prognosis compared with tumor
  confined to the stomach (non-AEG). Although the metabolic changes of non-AEG have
  been investigated in extensive studies, little effort focused on the metabolic profiling
  of AEG serum.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2">
  <h3 ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">The incidence of adenocarcinoma in the esophagogastric junction (AEG) has increased in the recent years. AEG is reported to have a worse prognosis compared with tumor confined to the stomach (non-AEG). Although the metabolic changes of non-AEG have been investigated in extensive studies, little effort focused on the metabolic profiling of AEG serum.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 ...